Cergutuzumab amunaleukin Antibody
Cergutuzumab amunaleukin (CEA-IL2v) is an immunocytokine designed to target carcinoembryonic antigen (CEA) -expressing tumors. Its engineered IL-2 variant promotes immune cell activation and is investigated in preclinical in vitro and in vivo studies for solid cancer immunotherapy.
Product Specifications
Product Name Alternative
Interleukin Related, CEA-IL2v, RG 7813, RO 6895882
Target
Interleukin
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
5.26 mg/mL
Purity
98.00% (May vary between batches)
Molecular Weight
162.05 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041037-500 1x 500 µL
CD44 Standard (DF1485), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880225-500 1x 500 µL
Major Vault Protein (MVP) (1032), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400201-500 1x 500 µL
CD2 / Lymphocyte Function Antigen 2 (LFA-2) (UMCD2), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881372-500 1x 500 µL
Ep-CAM / CD326 (Extracellular Domain) (Epithelial Marker) (EGP40/1372), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471798-500 1x 500 µL
Ep-CAM / CD326 (Extracellular Domain) (Epithelial Marker) (EGP40/1798), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details